Nuclear and cytoplasmic accumulation of Ep-ICD is frequently detected in human epithelial cancers.
We previously demonstrated that nuclear and cytoplasmic accumulation of the intracellular domain (Ep-ICD) of epithelial cell adhesion molecule (EpCAM) accompanied by a reciprocal reduction of its extracellular domain (EpEx), occurs in aggressive thyroid cancers. This study was designed to determine...
Main Authors: | Ranju Ralhan, Helen C-H He, Anthony K-C So, Satyendra C Tripathi, Manish Kumar, Md Raghibul Hasan, Jatinder Kaur, Lawrence Kashat, Christina MacMillan, Shyam Singh Chauhan, Jeremy L Freeman, Paul G Walfish |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2010-11-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC2994724?pdf=render |
Similar Items
-
Nuclear Ep-ICD expression is a predictor of poor prognosis in "low risk" prostate adenocarcinomas.
by: Jasmeet Assi, et al.
Published: (2015-01-01) -
EpCAM nuclear localization identifies aggressive Thyroid Cancer and is a marker for poor prognosis
by: MacMillan Christina, et al.
Published: (2010-06-01) -
Biotinidase is a novel marker for papillary thyroid cancer aggressiveness.
by: Anthony K-C So, et al.
Published: (2012-01-01) -
Programmed Death - Ligand 1 Expression Distinguishes Invasive Encapsulated Follicular Variant of Papillary Thyroid Carcinoma from Noninvasive Follicular Thyroid Neoplasm with Papillary-like Nuclear Features
by: Guodong Fu, et al.
Published: (2017-04-01) -
Anticancer Activity of Apaziquone in Oral Cancer Cells and Xenograft Model: Implications for Oral Cancer Therapy.
by: Gunjan Srivastava, et al.
Published: (2015-01-01)